A clinical case of asymptomatic drug-induced thrombocytopenia

Thrombocytopenia is a condition in which the level of platelets in the blood decreases and becomes less than 150×109/L. This can lead to an increased risk of bleeding. One of the causes of thrombocytopenia may be medication; its association with the use of more than 300 drugs has now been documented...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Zolotarev, E. A. Pyhtunova, O. Yu. Trifonova, S. I. Kseneva, V. V. Udut
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Siberian Branch Publishing House 2024-11-01
Series:Сибирский научный медицинский журнал
Subjects:
Online Access:https://sibmed.elpub.ru/jour/article/view/1722
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849318740283359232
author A. A. Zolotarev
E. A. Pyhtunova
O. Yu. Trifonova
S. I. Kseneva
V. V. Udut
author_facet A. A. Zolotarev
E. A. Pyhtunova
O. Yu. Trifonova
S. I. Kseneva
V. V. Udut
author_sort A. A. Zolotarev
collection DOAJ
description Thrombocytopenia is a condition in which the level of platelets in the blood decreases and becomes less than 150×109/L. This can lead to an increased risk of bleeding. One of the causes of thrombocytopenia may be medication; its association with the use of more than 300 drugs has now been documented. The pathogenesis of such, drug-induced thrombocytopenia (DITP), is described as a consequence of direct cytotoxic effects of drug on megakaryocytes, which leads to increased platelet destruction in the bloodstream or dysfunctional thrombopoiesis. In the diagnosis of DITP the leading role belongs to the clinical approach: first of all, it is carried out on the basis of data of drug history and a minimum set of laboratory tests, including counting the number of platelets in the blood and determining the clotting time. Since thrombocytopenia may be associated with the risk of serious bleeding, its timely diagnosis is of key importance for determining the tactics of therapeutic intervention. We present a clinical case of DITP, after the combined use of drugs of different groups – statin, xanthine oxidase inhibitor, cytostatic drug of antimetabolite group, non-selective beta- adrenoblocker and two non-steroidal anti-inflammatory drugs with different mechanism of action. The described case showed that to avoid polypharmacy in patients with DITP it is necessary to assess hemostatic potential by low-frequency piezotromboelastography, because even in conditions of insufficient platelet count they can provide preserved functional ability to maintain hemostasis.
format Article
id doaj-art-e4a643772f224d17912e89fbac67ff55
institution Kabale University
issn 2410-2512
2410-2520
language Russian
publishDate 2024-11-01
publisher Russian Academy of Sciences, Siberian Branch Publishing House
record_format Article
series Сибирский научный медицинский журнал
spelling doaj-art-e4a643772f224d17912e89fbac67ff552025-08-20T03:50:44ZrusRussian Academy of Sciences, Siberian Branch Publishing HouseСибирский научный медицинский журнал2410-25122410-25202024-11-0144519420010.18699/SSMJ20240523698A clinical case of asymptomatic drug-induced thrombocytopeniaA. A. Zolotarev0E. A. Pyhtunova1O. Yu. Trifonova2S. I. Kseneva3V. V. Udut4Research Institute of Pharmacology and Regenerative Medicine E.D. Goldberg Tomsk National Research Medical Center of the RASResearch Institute of Pharmacology and Regenerative Medicine E.D. Goldberg Tomsk National Research Medical Center of the RASResearch Institute of Pharmacology and Regenerative Medicine E.D. Goldberg Tomsk National Research Medical Center of the RASResearch Institute of Pharmacology and Regenerative Medicine E.D. Goldberg Tomsk National Research Medical Center of the RASResearch Institute of Pharmacology and Regenerative Medicine E.D. Goldberg Tomsk National Research Medical Center of the RASThrombocytopenia is a condition in which the level of platelets in the blood decreases and becomes less than 150×109/L. This can lead to an increased risk of bleeding. One of the causes of thrombocytopenia may be medication; its association with the use of more than 300 drugs has now been documented. The pathogenesis of such, drug-induced thrombocytopenia (DITP), is described as a consequence of direct cytotoxic effects of drug on megakaryocytes, which leads to increased platelet destruction in the bloodstream or dysfunctional thrombopoiesis. In the diagnosis of DITP the leading role belongs to the clinical approach: first of all, it is carried out on the basis of data of drug history and a minimum set of laboratory tests, including counting the number of platelets in the blood and determining the clotting time. Since thrombocytopenia may be associated with the risk of serious bleeding, its timely diagnosis is of key importance for determining the tactics of therapeutic intervention. We present a clinical case of DITP, after the combined use of drugs of different groups – statin, xanthine oxidase inhibitor, cytostatic drug of antimetabolite group, non-selective beta- adrenoblocker and two non-steroidal anti-inflammatory drugs with different mechanism of action. The described case showed that to avoid polypharmacy in patients with DITP it is necessary to assess hemostatic potential by low-frequency piezotromboelastography, because even in conditions of insufficient platelet count they can provide preserved functional ability to maintain hemostasis.https://sibmed.elpub.ru/jour/article/view/1722thrombocytopeniapolypharmacyhemostasiscytostatic therapymethotrexate
spellingShingle A. A. Zolotarev
E. A. Pyhtunova
O. Yu. Trifonova
S. I. Kseneva
V. V. Udut
A clinical case of asymptomatic drug-induced thrombocytopenia
Сибирский научный медицинский журнал
thrombocytopenia
polypharmacy
hemostasis
cytostatic therapy
methotrexate
title A clinical case of asymptomatic drug-induced thrombocytopenia
title_full A clinical case of asymptomatic drug-induced thrombocytopenia
title_fullStr A clinical case of asymptomatic drug-induced thrombocytopenia
title_full_unstemmed A clinical case of asymptomatic drug-induced thrombocytopenia
title_short A clinical case of asymptomatic drug-induced thrombocytopenia
title_sort clinical case of asymptomatic drug induced thrombocytopenia
topic thrombocytopenia
polypharmacy
hemostasis
cytostatic therapy
methotrexate
url https://sibmed.elpub.ru/jour/article/view/1722
work_keys_str_mv AT aazolotarev aclinicalcaseofasymptomaticdruginducedthrombocytopenia
AT eapyhtunova aclinicalcaseofasymptomaticdruginducedthrombocytopenia
AT oyutrifonova aclinicalcaseofasymptomaticdruginducedthrombocytopenia
AT sikseneva aclinicalcaseofasymptomaticdruginducedthrombocytopenia
AT vvudut aclinicalcaseofasymptomaticdruginducedthrombocytopenia
AT aazolotarev clinicalcaseofasymptomaticdruginducedthrombocytopenia
AT eapyhtunova clinicalcaseofasymptomaticdruginducedthrombocytopenia
AT oyutrifonova clinicalcaseofasymptomaticdruginducedthrombocytopenia
AT sikseneva clinicalcaseofasymptomaticdruginducedthrombocytopenia
AT vvudut clinicalcaseofasymptomaticdruginducedthrombocytopenia